SARA VANLANINGHAM

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family WARSAW, IN NPI 1013469659

General Payments — all program years on this page

$1,260.05

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 80
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $435.79 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $435.7922

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $12.281
2022 $569.1642
2023 $242.8215
2024 $435.7922

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100355434 Novo Nordisk Inc $19.06 07/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100403904 Novo Nordisk Inc $17.21 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100575330 Novo Nordisk Inc $16.23 10/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100622198 Novo Nordisk Inc $16.86 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100622964 Novo Nordisk Inc $19.55 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104251737 AstraZeneca Pharmaceuticals LP $15.39 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104573990 AstraZeneca Pharmaceuticals LP $18.31 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105639650 AstraZeneca Pharmaceuticals LP $17.80 06/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105811053 AstraZeneca Pharmaceuticals LP $14.01 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106968793 ABBVIE INC. $19.14 03/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106968795 ABBVIE INC. $16.80 05/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106968797 ABBVIE INC. $24.72 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114624333 Exact Sciences Corporation $14.13 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119051928 Otsuka America Pharmaceutical, Inc. $17.15 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1124797019 Abbott Laboratories $16.41 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135861734 Lilly USA, LLC $13.62 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135939992 Lilly USA, LLC $21.51 12/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146009731 Lundbeck LLC $14.00 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146009733 Lundbeck LLC $14.00 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148406648 Axsome Therapeutics, Inc. $19.20 08/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150134437 SHIELD THERAPEUTICS INC $14.92 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150142438 SHIELD THERAPEUTICS INC $75.77 08/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.